Sign In
Buy RAD
$0.648
+0 (+0%)
At Close: Jan 12, 2024
Rite Aid On-Demand Delivery Goes National with Uber Eats
01:52pm, Friday, 24'th Sep 2021
Rite Aid on Friday (Sept. 24) broadened its partnership with Uber Technologies, Inc., and is now offering delivery of healthcare items, groceries and Rite Aid products through the Uber Eats platform f
Rite Aid (RAD) Q2 Loss Narrower Than Expected, Revenues Miss
11:30am, Friday, 24'th Sep 2021
Despite high costs, Rite Aid's (RAD) fiscal second-quarter results have been aided by increased demand as well as strength in Elixir and the Retail Pharmacy unit.
Rite Aid Partners With Uber Eats to Expand On-Demand Delivery Nationwide
10:02am, Friday, 24'th Sep 2021
PHILADELPHIA--(BUSINESS WIRE)--Today, Rite Aid (NYSE: RAD) announced the expansion of their partnership with Uber Technologies, Inc. (NYSE: UBER) to offer delivery of Rite Aid products nationwide thro
Rite Aid Corporation (RAD) CEO Heyward Donigan on Q2 2022 Results - Earnings Call Transcript
02:25pm, Thursday, 23'rd Sep 2021
Rite Aid Corporation (RAD) CEO Heyward Donigan on Q2 2022 Results - Earnings Call Transcript
Rite Aid Touts Importance of Pharmacists in Business Growth
11:00am, Thursday, 23'rd Sep 2021
Rite Aid is pointing to pharmaceuticals and its pharmacists as the key to growing and transforming its business, though bigger competitors whose strategies are more developed may put some speed bumps
Rite Aid Shares Crumble After Expecting Wider Annual Net Loss For Fiscal 2022
10:06am, Thursday, 23'rd Sep 2021
Rite Aid Corporation (NYSE: RAD) has reported Q2 FY22 adjusted net loss of ($0.41) per share, compared to an income of $0.25 a year ago, but beating the consensus of $(0.48). Earnings: Revenues in
Rite Aid (RAD) Reports Q2 Loss, Misses Revenue Estimates
09:55am, Thursday, 23'rd Sep 2021
Rite Aid (RAD) delivered earnings and revenue surprises of 2.38% and -2.13%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid reports narrower-than-expected loss, but revenue misses and full-year loss outlook widens
07:17am, Thursday, 23'rd Sep 2021
Shares of Rite Aid Corp. RAD, +1.06% edged up 0.7% in premarket trading Thursday, after the drugstore chain reported a narrower-than-expected fiscal second-quarter loss, citing "strong execution" of C
Earnings Previews: BlackBerry, Rite Aid
11:03am, Tuesday, 21'st Sep 2021
The first earnings reports we have covered for this week are coming after Tuesday's closing bell and before Wednesday's open: Adobe, FedEx, General Mills and Stitch Fix.
Rite Aid (RAD) to Report Q2 Earnings: What Should You Know?
11:28am, Monday, 20'th Sep 2021
Rite Aid (RAD) is likely to have gained from PBM, RxEvolution strategy and expanded omnichannel services in Q2. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Today's Stock Market News & Events: 9/20/2021
07:19am, Monday, 20'th Sep 2021
Wall Street can expect a busy start to the latter part of September as this week is packed full of economic data.
Earnings Preview: Rite Aid (RAD) Q2 Earnings Expected to Decline
04:49pm, Thursday, 16'th Sep 2021
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lance Neill Joins Elixir as New Chief Operating Officer
12:08pm, Tuesday, 07'th Sep 2021
CAMP HILL, Pa.--(BUSINESS WIRE)--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD) that provides pharmacy benefits and services, today announced that veteran healthcare and pharmacy executive
Rite Aid to Release Second Quarter Results on September 23
04:15pm, Friday, 03'rd Sep 2021
CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE:RAD) said today that it will release financial results for its Fiscal 2022 Second Quarter, which ended Aug. 28, 2021, on Thursday, Sept. 23,
Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock
02:04pm, Wednesday, 11'th Aug 2021
Bio-Rad (BIO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
